LGC in partnership with ATCC

30/09/2024

MicroRNAs (miRs) are thought to play a role in 🔀

In a multi-institution study led by University of Westminster, scientists used an array of ATCC to examine the role of miR-21 in — learn more IJMS MDPI: https://okt.to/CDq1A0

25/09/2024

Apoptosis is a key goal for therapies, but apoptotic pathways can be non-functional ❌

A team of researchers at Πανεπιστήμιο Αθηνών - University of Athens used ATCC to see whether could help — read on Cancers MDPI: https://okt.to/C1Ku4U

Apoptosis induction is a common therapeutic approach. However, many cancer cells are resistant to apoptotic death and alternative cell death pathways including pyroptosis and necroptosis need to be triggered. At the same time, danger signals that include HMGB1 and HSP70 can be secreted/released by d...

23/09/2024

How do epidermal growth factor receptors (EGFRs) mediate progression via the microenvironment? 🧫

Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale" scientists used ATCC & non-cancer to find out — learn more at Cancers MDPI: https://okt.to/tX0AR9

19/09/2024

In today's paper, a team of researchers at Philip Morris International used to investigate the impact of anatabine on cellular systems 🔬

The work included experimental cell culture with an ATCC neuroblastoma — read on at Frontiers - Pharmacology and Toxicology: https://okt.to/BjPQxg

18/09/2024

In today's paper, scientists from Universidade da Beira Interior - UBI and Universidade de Coimbra used four different ATCC to examine different steroidal derivatives as potential drug candidates 🧫 ➡️ 💊

Read on at Molecules MDPI: https://okt.to/9aPd2D

A series of novel 21E-arylidene-4-azapregn-5-ene steroids has been successfully designed, synthesized and structurally characterized, and their antiproliferative activity was evaluated in four different cell lines. Within this group, the 21E-(pyridin-3-yl)methylidene derivative exhibited significant...

17/09/2024

Scientists from Max Delbrück Center and Heinrich-Heine-Universität Düsseldorf have used brain to uncover a new gene target for the treatment of 🧠

The study suggests mutations may damage brain development before clinical symptoms appear — read on at The European Animal Research Association (EARA): https://okt.to/DGHpgs

Using 3D brain organoids, researchers have linked a gene with Huntington’s disease for the first time, which may provide a new target for treatment.Huntington’s is an incurable neurodegenerative disorder that affects movement, thinking ability and mental health. It is caused by mutations in the ...

13/09/2024

therapies may help patients with a history of , but carry a risk of reactivation 🔁

Uniwersytet Mikołaja Kopernika w Toruniu scientists used ATCC bladder carcinoma & hTERT-immortalised ASC52telo to investigate. Read on Life MDPI: https://okt.to/HriBRy

12/09/2024

are important in 🦠

Using ATCC human primary fibroblasts, scientists from NOVA FCT explored the use of silver-gold to eradicate biofilms — see what they found at Frontiers - Microbiology:
https://okt.to/MoHFS1

Bacterial biofilm is a tri-dimensional complex community of cells at different metabolic stages involved in a matrix of self-produced extracellular polymeric...

11/09/2024

In today's study, scientists from Medizinische Hochschule Hannover/ MHHnova used our human MCF-10A epithelial to explore the effect of a common drug on different biological pathways 💊🧫

Read the Cells MDPI paper here: https://okt.to/FPb2yD

04/09/2024

Could gas plasma technology be an effective treatment? 🧠

In today's study, scientists at INP Greifswald cultured ATCC HaCaT keratinocyte and glioblastoma to investigate — learn more at Cancers MDPI: https://okt.to/7Po4By

Glioblastoma multiforme (GBM) is the most common primary malignant adult brain tumor. Therapeutic options for glioblastoma are maximal surgical resection, chemotherapy, and radiotherapy. Therapy resistance and tumor recurrence demand, however, new strategies. Several experimental studies have sugges...

02/09/2024

In a recent Nature Biotechnology paper, researchers from the Technical University of Munich have shared a new technique that maps drug-protein interactions 💊

The technique may help repurpose pre-existing treatments — learn more at Technology Networks:
https://okt.to/UEQhPT

A new technique may help reveal unknown benefits of existing drugs, according to a new study. The new approach, called decryptE, could help identify new applications for already approved drugs and take steps toward precision medicine.

30/08/2024

Today we're sharing a new study from the team at NIB National Institute of Biology, Slovenia, who used patient-derived to research treatment response! 🔬🧫

Read the paper at iScience journal: https://okt.to/JlH4f0